Pfizer-BioNTech Submit Request for Emergency Use of Pediatric COVID-19 Vaccine
The Companies recently submitted data from a phase 2/3 trial that included 2268 pediatric participants.
Pediatric Rheumatology
COVID-19 Vaccines Safe and Well Tolerated Among Patients With Juvenile Idiopathic Arthritis Receiving TNF Inhibitors
Researchers evaluated the safety and tolerability of the BNT162b2 COVID-19 vaccine in adolescents with juvenile idiopathic arthritis receiving TNF inhibitors.
Pandemic Anxiety Among Adolescents Associated With Depression, Poor Health
A team of investigators assessed the impact of the COVID-19 pandemic on the mental and physical health of adolescents.
Antibodies Identified in Neonates of Women Vaccinated Against COVID-19
Neonates born to women vaccinated against COVID-19 during pregnancy have high levels of antibodies to the spike protein.
Lower-Dose COVID-19 Vaccine Appears Safe, Immunogenic in Children Aged 5 to 11 Years
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
Pediatric Dialysis Population With Lupus Nephritis Fare Worse Than Those With Nonlupus Glomerular Disease
Among children on dialysis, those with lupus nephritis were more likely to be hospitalized.
Multisystem Inflammatory Syndrome in Children vs Kawasaki Disease vs Macrophage Activating Syndrome Due to Systemic JIA
Using real-world data, researchers compared the clinical findings of multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activating syndrome due to systemic juvenile idiopathic arthritis.
Sociodemographic Disparities in Stressful Life Events Reported Among Children
Overall, 6.8% of children age 5 to 17 years were victims of or witnessed violence in their neighborhood in 2019.
Rituximab for Refractory Lupus Nephritis and Flare: Pediatric Rheumatologists vs Nephrologists
Using a web-based survey, study authors assessed the current practices of pediatric nephrologists and rheumatologists in North America with regard to the treatment of refractory proliferative lupus nephritis.
Implementation of a Universal Access Program May Improve Health Care Quality in Juvenile Idiopathic Arthritis
In an editorial piece, Roberta Berard, MD, and Michelle Batthish, MD, highlight the role of a universal access program in improving the health care quality in juvenile idiopathic arthritis.
- Loading...
Loading...
Next post in Pediatric Rheumatology
Loading... 
Loading...